Editor's Note A low-cost blood test for troponin, a protein released during heart muscle damage, significantly improves long-term risk prediction for heart attacks and strokes—especially in patients with intermediate cardiovascular risk, according to an April 7 report from News-Medical.Net. The findings, based on a large-scale international study led by the…
Editor's Note Researchers have developed a fully dissolvable, needle-injectable pacemaker that regulates heart rhythms without requiring surgical removal. As detailed in an April 2 article in Scientific American, the miniature device—just millimeters in size—can deliver electrical stimulation for days to weeks before safely breaking down in the body, potentially reducing…
Editor's Note A nurse-coordinated prevention program significantly lowered the long-term risk of major adverse cardiovascular events (MACE) in adults recovering from acute coronary syndrome (ACS), according to an April 2 article in Healio. The program, which focused on lifestyle and behavioral changes, led to a 30% reduction in adverse events,…
Editor's Note The widespread adoption of GLP-1 weight-loss medications like Ozempic and Wegovy could put revenue at risk across multiple service lines, according to a March 11 article in Becker’s Hospital Review. As a result, hospitals and ambulatory surgery centers (ASCs) face critical questions about how to adapt. The article…